Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2016 - 2026)
Fulgent Genetics' Depreciation & Amortization (CF) history spans 12 years, with the latest figure at $6.0 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 1.37% to $6.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $18.1 million, a 0.81% decrease, with the full-year FY2025 number at $24.1 million, down 3.23% from a year prior.
- Depreciation & Amortization (CF) hit $6.0 million in Q1 2026 for Fulgent Genetics, down from $6.1 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for FLGT hit a ceiling of $9.8 million in Q3 2022 and a floor of $110000.0 in Q3 2025.
- Historically, Depreciation & Amortization (CF) has averaged $6.0 million across 5 years, with a median of $6.2 million in 2024.
- Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 245.12% in 2022 and later crashed 97.37% in 2024.
- Tracing FLGT's Depreciation & Amortization (CF) over 5 years: stood at $9.8 million in 2022, then plummeted by 33.35% to $6.5 million in 2023, then dropped by 5.22% to $6.2 million in 2024, then fell by 1.29% to $6.1 million in 2025, then dropped by 1.83% to $6.0 million in 2026.
- Business Quant data shows Depreciation & Amortization (CF) for FLGT at $6.0 million in Q1 2026, $6.1 million in Q4 2025, and $110000.0 in Q3 2025.